60 Degrees Pharmaceuticals (SXTP) announced a partnership with Runway Health to expand pre-departure access to ARAKODA for prevention of malaria among international travelers through the Runway Health travel medicine platform. The partnership with Runway Health commences April 2, 2026. It adds a new platform to the 60 Degrees Pharma ARAKODA marketing strategy, where eligible users can match their travel itinerary with a personalized medical treatment plan designed by a U.S. licensed healthcare provider.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SXTP:
- 60 Degrees Pharmaceuticals Implements One-for-Four Reverse Split
- Upcoming Stock Splits This Week (January 20 to January 23) – Stay Invested
- 60 Degrees Pharmaceuticals Inc trading halted, news pending
- 60 Degrees Pharmaceuticals announces approval of 1-for-4 reverse stock split
- 60 Degrees Pharma outlines growth strategy in investor webinar